| Financial Year |
March 31 2023 |
| Monetary Funds |
238,807,525.49 |
| Held-for-trading Financial Assets |
136,625.00 |
| Notes Receivable |
3,334,500.00 |
| Accounts Receivable |
8,371,985.36 |
| Advances to Suppliers |
18,522,549.20 |
| Other Receivables |
28,166,778.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
320,976,913.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,148,127.97 |
| Total Current Assets |
627,465,005.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
123,868,800.13 |
| Investment Properties |
-- |
| Fixed Assetes |
661,343,320.36 |
| Under-construction Projects |
95,810,608.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
889,759,476.04 |
| R&D expenses |
-- |
| Goodwill |
11,485,733.27 |
| Long-Term Deferred and Prepaid Expenses |
28,309,470.19 |
| Deferred Income Tax Assets |
3,809,730.76 |
| Other Non-Current Assets |
13,590,660.00 |
| Sub-Total of Non-Current Assets |
1,829,819,960.20 |
| Total Assets |
2,457,284,965.66 |
| Short-Term Loans |
497,311,298.52 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,387,409.59 |
| Accounts Payable |
173,865,171.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,279,718.26 |
| Taxes Payable |
9,249,478.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
107,235,685.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,832,460.13 |
| Other Current Liabilities |
17,098,813.97 |
| Sub-Total of Current Liabilities |
947,789,373.84 |
| Long-term Loans |
99,940,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
40,479,629.31 |
| Special Payable |
-- |
| Estimatied Liabilities |
61,963,477.24 |
| Deferred Income Tax Liabilities |
18,020,020.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
238,465,208.01 |
| Total Liabilities |
1,186,254,581.85 |
| Paid-In Capital(Or Share Stock) |
323,395,267.00 |
| Capital Surplus |
1,495,452,326.53 |
| Surplus Reserve |
34,308,111.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-637,479,529.93 |
| Minority Stockholder's Interest |
42,913,874.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,228,116,509.24 |
| Owner's Equity（Stockholder's Equity） |
1,271,030,383.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,457,284,965.66 |
